Clone 57/3 recognizes Estrogen Receptor Beta (ER?) 2 and is useful in determining the expression of ER?2 in cancer cells via various analysis methods.
| Institute |
|---|
| BioServ UK Ltd |
| Cat. #: | 153632 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Cancer types: | Ovarian cancer, Breast cancer |
| Research Fields: | Cancer;Immunology |
| Application: | IHC ; IF ; WB |
| Target: | Estrogen Receptor ? 2 |
| Reactivity: | Human |
| Clone: | 57/3 |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Estrogen receptor beta, ER-beta, Nuclear receptor subfamily 3 group A member 2 |
|---|---|
| Product description: | Estrogen receptors are commonly over-expressed in cancers. Clone 57/3 recognizes Estrogen Receptor Beta (ERÄÂ?) 2 and is useful in determining the expression of ERÄÂ?2 in cancer cells via various analysis methods. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 53 kDa |
| Immunogen: | Recognizes ER?2 isomer at sequence CGMKMETLLPEATMEQ |
| Myeloma used: | Sp2/0-Ag14 |
| Target background: | Estrogen receptors are commonly over-expressed in cancers. Clone 57/3 recognizes Estrogen Receptor Beta (ER?) 2 and is useful in determining the expression of ER?2 in cancer cells via various analysis methods. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Buttarelli et al. 2017. Gynecol Oncol. 145(2):352-360. PMID: 28228232. Hormone receptor expression profile of low-grade serous ovarian cancers. Zannoni et al. 2016. Histopathology. 68(4):541-8. PMID: 26132417. Sexual dimorphism in medulloblastoma features. Gender effect in experimental models of human medulloblastoma: does the estrogen receptor ? signaling play a role? Ciucci et al. 2014. PLoS One. 9(7):e101623. PMID: 25000562. Collins et al. 2009. BMC Cancer. 9:330. PMID: 19758455. Expression of oestrogen receptors, ERalpha, ERbeta, and ERbeta variants, in endometrial cancers and evidence that prostaglandin F may play a role in regulating expression of ERalpha. Carpino et al. 2007. Eur J Endocrinol. 157(2):239-44. PMID: 17656605. Detection of aromatase and estrogen receptors (ERalpha, ERbeta1, ERbeta2) in human Leydig cell tumor. Skliris et al. 2006. Br J Cancer. 95(5):616-26. PMID: 16880783. Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Wong et al. 2005. J Pathol. 207(1):53-60. PMID: 15954165. ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. Sierens et al. 2004. J Mol Endocrinol. 32(3):703-18. PMID: 15171710. Cloning of oestrogen receptor beta from Old and New World primates: identification of splice variants and Fn analysis. Critchley et al. 2002. J Clin Endocrinol Metab. 87(11):5265-73. PMID: 12414901. Wild-type estrogen receptor (ERbeta1) and the splice variant (ERbetacx/beta2) are both expressed within the human endometrium throughout the normal menstrual cycle. Ogawa et al. 1998. Nucleic Acids Res. 26(15):3505-12. PMID: 9671811. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.